These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20530068)

  • 1. GlaxoSmithKline denies it has settled thousands of lawsuits over rosiglitazone (Avandia).
    Tanne JH
    BMJ; 2010 Jun; 340():c3010. PubMed ID: 20530068
    [No Abstract]   [Full Text] [Related]  

  • 2. GSK fights compensation claims from UK patients who took rosiglitazone.
    Dyer C
    BMJ; 2013 Feb; 346():f695. PubMed ID: 23377792
    [No Abstract]   [Full Text] [Related]  

  • 3. In brief: rosiglitazone (Avandia) unbound.
    Med Lett Drugs Ther; 2014 Feb; 56(1435):12. PubMed ID: 24662977
    [No Abstract]   [Full Text] [Related]  

  • 4. Outlook on diabetes drug less than rosy. Early work suggests that rosiglitazone (Avandia) may not be best for the heart.
    Harv Heart Lett; 2007 Aug; 17(12):1-2. PubMed ID: 17717888
    [No Abstract]   [Full Text] [Related]  

  • 5. Rosiglitazone, marketing, and medical science.
    Moynihan R
    BMJ; 2010 Apr; 340():c1848. PubMed ID: 20375091
    [No Abstract]   [Full Text] [Related]  

  • 6. The Avandia debate.
    Bloomgarden ZT
    Diabetes Care; 2007 Sep; 30(9):2401-8. PubMed ID: 17726191
    [No Abstract]   [Full Text] [Related]  

  • 7. Diabetes drug safety update: Avandia and your heart.
    Johns Hopkins Med Lett Health After 50; 2010 Jun; 22(4):1-2, 7. PubMed ID: 20572316
    [No Abstract]   [Full Text] [Related]  

  • 8. [Increased risk of myocardial infarction following rosiglitazone?].
    Hjelmesaeth J
    Tidsskr Nor Laegeforen; 2007 Jun; 127(13):1809. PubMed ID: 17599146
    [No Abstract]   [Full Text] [Related]  

  • 9. Heart-stopping news. The diabetes drug Avandia is under fire: what you should know. Interview by Avery Comarow.
    Psaty B
    US News World Rep; 2007 Jun; 142(20):64. PubMed ID: 17632813
    [No Abstract]   [Full Text] [Related]  

  • 10. The Avandia debate: an unhappy conclusion.
    Bloomgarden Z; Handelsman Y
    J Diabetes; 2010 Dec; 2(4):221-2. PubMed ID: 20923505
    [No Abstract]   [Full Text] [Related]  

  • 11. Rosiglitazone and myocardial infarction: cause for concern or misleading meta-analysis?
    Bilous RW
    Diabet Med; 2007 Sep; 24(9):931-3. PubMed ID: 17725705
    [No Abstract]   [Full Text] [Related]  

  • 12. Rosiglitazone: opening Pandora's black box?
    Gilbert RE
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1329-31. PubMed ID: 17928463
    [No Abstract]   [Full Text] [Related]  

  • 13. The rosiglitazone meta-analysis.
    McCullough PA; Lepor NE
    Rev Cardiovasc Med; 2007; 8(2):123-6. PubMed ID: 17603430
    [No Abstract]   [Full Text] [Related]  

  • 14. Avandia in perspective.
    Comarow A
    US News World Rep; 2007 Oct; 143(11):71. PubMed ID: 17957906
    [No Abstract]   [Full Text] [Related]  

  • 15. Analytical issues regarding rosiglitazone meta-analysis.
    Claggett B; Wei LJ
    Arch Intern Med; 2011 Jan; 171(2):179-80; author reply 180. PubMed ID: 21263111
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug safety. Heart attack risk overshadows a popular diabetes therapy.
    Couzin J
    Science; 2007 Jun; 316(5831):1550-1. PubMed ID: 17569830
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiac safety profile of rosiglitazone: a comprehensive meta-analysis of randomized clinical trials.
    Mannucci E; Monami M; Di Bari M; Lamanna C; Gori F; Gensini GF; Marchionni N
    Int J Cardiol; 2010 Aug; 143(2):135-40. PubMed ID: 19328563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The truth about rosiglitazone (avandia).
    Ledbetter C; Laustsen G
    Nurse Pract; 2008 Jun; 33(6):10-1. PubMed ID: 18528195
    [No Abstract]   [Full Text] [Related]  

  • 19. Why the Avandia scandal proves big pharma needs stronger ethical standards.
    Philpott S; Baker R
    Bioethics; 2010 Oct; 24(8):ii-iii. PubMed ID: 21050246
    [No Abstract]   [Full Text] [Related]  

  • 20. Avandia outcome may signal change in epidemiologists' sway.
    Wadman M
    Nat Med; 2010 Jun; 16(6):614. PubMed ID: 20526293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.